| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 68412-53-3 | 聚(氧代-1,2-亚乙基)-α-支链的壬基苯基-ω-羟基-磷酸酯 | poly(oxy-1,2-ethanediyl), alpha-(nonylphenyl)- omega -hydroxy-, branched, phhates | 无 | C9-Branchedalkylphenol,ethoxylate | 详情 | 供应商 |
| 77470-90-7 | Hexanamide,N-(2,6-dimethylphenyl)-5-hydroxy-; 5hhX | ![]() | C14H21NO2 | 详情 | 供应商 | |
| 13595-83-0 | Nitric acid,dihydroxybismuthinyl ester; Bismuthhydroxide nitrate (Bi(OH)2(NO3)) (9CI); Bismuth hydroxide nitrate (Bi(OH)2NO3)(7CI,8CI) | ![]() | BiH2NO5 | 详情 | 供应商 | |
| 221054-70-2 | Oxepino[3,4-c]pyridine-3,9-dione,5-ethyl-1,4,5,8-tetrahydro-5-hydroxy-, (5R)-; (+)-EhhOPD | ![]() | C11H13NO4 | 详情 | 供应商 | |
| 9002-72-6 | 生长素; 生长激素; 躯体刺激素 | somatotropin; adenohypophysealgrowthhormone; anteriorpituitarygrowthhormone; hormonesomatotrope | 无 | C990H1529N263O299S7 | 详情 | 供应商 |
| 109376-82-1 | 1H-1,4-Diazepine,1-[(5-bromo-1-naphthalenyl)sulfonyl]hexahydro-; hh 3509 | ![]() | C15H17BrN2O2S | 详情 | 供应商 | |
| 109376-81-0 | 1H-1,4-Diazepine,hexahydro-1-[(6-iodo-1-naphthalenyl)sulfonyl]-; hh 3909 | ![]() | C15H17IN2O2S | 详情 | 供应商 | |
| 109376-79-6 | 1H-1,4-Diazepine,1-[(6-chloro-1-naphthalenyl)sulfonyl]hexahydro-; hh 3709 | ![]() | C15H17ClN2O2S | 详情 | 供应商 | |
| 109376-78-5 | 1H-1,4-Diazepine,hexahydro-1-(1-naphthalenylsulfonyl)-; hh 3209 | ![]() | C15H18N2O2S | 详情 | 供应商 | |
| 91826-20-9 | 1-29-Somatoliberin (rathypothalamus), 29-L-argininamide- (9CI); Rat growthhormone-releasing factor(1-29) amide; Rat growth hormone-releasingfactor(1-29)-NH2; Rat hypothalamic GRF(1-29)-NH2 | ![]() | C155H251N49O40S | 详情 | 供应商 | |
| 65400-98-8 | 5-Pyrimidinecarboxamide,N-(3,4-dichlorophenyl)hexahydro-1,3-dimethyl-2,4,6-trioxo-; Fenoxacrim; hhP | ![]() | C13H11Cl2N3O4 | 详情 | 供应商 | |
| 104339-66-4 | ASP-SER-HIS-ALA-LYS-ARG-HIS-HIS-GLY-TYR-LYS-ARG-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR; ASP- | HISTATIN-5; DSHAKRhhGYKRKFHEKhhSHRGY; H-ASP-SER-HIS-ALA-LYS-ARG-HIS-HIS-GLY-TYR-LYS-ARG-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR-OH; HISTATIN-5; HISTATIN 5 (HUMAN); ASP-SER-HIS-ALA-LYS-ARG-HIS-HIS-GLY-TYR-LYS-ARG-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR; Histatin 5【human parotid saliva】; L-Asp-L-Ser-L-His-L-Ala-L-Lys-L-Arg-L-His-L-His-Gly-L-Tyr-L-Lys-L-Arg-L-Lys-L-Phe-L-His-L-Glu-L-Lys-L-His-L-His-L-Ser-L-His-L-Arg-Gly-L-Tyr-OH | ![]() | C133H195N51O33 | 详情 | 供应商 |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLhhLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLhhLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLhhLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLhhLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |